-
Loading metrics
Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study
- Shelagh M. Szabo,
- Ishan Hirji,
- Karissa M. Johnston,
- Ariadna Juarez-Garcia,
- Joseph M. Connors
x
- Published: October 9, 2017
- https://doi.org/10.1371/journal.pone.0180261